-
Jun 30, 2022, 09:17 AM
by
#1 AI clinical analytics platform company Saama Technologies welcomes global life sciences industry expert Vivek Sharma as new CEO
Full story
-
Jun 30, 2022, 09:15 AM
by
Leadership Team Expansion Follows Year of Accelerated Growth
Full story
-
Jun 30, 2022, 09:14 AM
by
PHASTAR Names Chris Schoonmaker as Chief Operations Officer
London, UK and Durham, NC - June 29, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Chris Schoonmaker has joined the company as Chief Operations Officer. Chris will direct PHASTAR’s operational strategy with a key focus on ensuring quality deliverables and providing a positive customer experience.
Full story
-
Jun 30, 2022, 01:00 AM
by
User Not Found
Bio-IT World | A comprehensive ligand- and structure-based design platform delivers new and improved features for molecule design; an advanced automated GC headspace sampler and GC/mass spectrometry solution helps lab teams simplify operations; 10x Genomics releases a series of profiling products; and more.
Full story
-
Jun 29, 2022, 09:18 AM
by
Full story
-
Jun 29, 2022, 09:16 AM
by
Full story
-
Jun 29, 2022, 09:15 AM
by
Citeline and Norstella Unite to create a new organization that will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient
Full story
-
Jun 29, 2022, 09:15 AM
by
BOC Sciences demonstrates its comprehensive strength with innovative LYTAC degradation technology solutions developed in the field of targeted protein degradation.
Full story
-
Jun 29, 2022, 09:14 AM
by
Creative Biogene offers one-stop mitochondria-focused testing services for the evaluation of a variety of cardiac diseases associated with mitochondrial dysfunction.
Full story
-
Jun 29, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Funding for single-cell sequencing, small molecule drug discovery, neurological biomarkers, and more.
Full story
-
Jun 28, 2022, 09:23 AM
by
MMS Holdings, a contract research organization, announced today that Lindsay Goldberg, a private equity firm, has completed an investment in the company. The partnership will help MMS expand its data-focused clinical research services.
Full story
-
Jun 28, 2022, 09:18 AM
by
Full story
-
Jun 28, 2022, 09:17 AM
by
Full story
-
Jun 28, 2022, 09:16 AM
by
Full story
-
Jun 28, 2022, 09:15 AM
by
University of Maryland Medicine Precision Health Study Utilizes Vibrent Health’s Accessible and Scalable Online Platform with a Goal to Enroll 250,000 Diverse Maryland Residents to Learn How Genes and Other Factors Affect Health
Full story
-
Jun 28, 2022, 01:00 AM
by
User Not Found
Bio-IT World | In the latest episode of Bio-IT World’s Trends from the Trenches podcast, Susan Gregurick, Associate Director for Data Science and Director of the Office of Data Science Strategy at the National Institutes of Health, gave a peek into what’s coming in the next iteration of the NIH Strategic Plan for Data Science.
Full story
-
Jun 27, 2022, 10:48 AM
by
Senior Vice President Rachael Jones to co-chair RISE event focused on improving quality of care and member experience
Full story
-
Jun 27, 2022, 10:48 AM
by
ObvioHealth, a global virtual research organization (VRO), is bringing clinical trial data fully into the continuum of care through a new strategic partnership with Dedalus Group, the leading healthcare and diagnostic software solutions provider in Europe.
Full story
-
Jun 27, 2022, 10:48 AM
by
On PTSD Awareness Day, MAPS PBC announces plans to develop the New Drug Application for MDMA-assisted therapy in collaboration with MMS Holdings
The second Phase 3 trial of the Breakthrough-Designated Therapy for PTSD will be completed in late 2022, with a targeted NDA submission in 2023 supported by MMS Holdings
MMS Holdings, which specializes in supporting first-in-class NDAs, was selected for extensive experience in neuroscience
Full story
-
Jun 27, 2022, 10:47 AM
by
Full story